A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)
Clinical trial NCT04598451 · COMPLETED
Trial details
- NCT number
- NCT04598451
- Sponsor
- argenx
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2023-08-22
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.